Cryo-Cell International 

$6.78
16
+$0.23+3.51% Friday 19:53

Statistik

Harga Tertinggi Hari
6.75
Harga Terendah Hari
6.75
52M Tertinggi
9.5
52M Terendah
3.67
Volum
827
Volum Purata
4,408
Kapasiti Pasaran
49.98M
Nisbah P/E
-
Pendapatan Dividen
-
Dividen
-

Akan Datang

Dividen

0%Pendapatan Dividen
Pertumbuhan 10T
N/A
Pertumbuhan 5T
N/A
Pertumbuhan 3T
N/A
Pertumbuhan 1T
N/A

Pendapatan

11OctDijangka
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Seterusnya
-1.35
-0.82
-0.3
0.23
EPS yang dijangka
0.03
EPS sebenar
N/A

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti CCEL. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.

Mengenai

Services to the Health Industry
Health Services
Health Technology
Medical Specialties
Manufacturing
Dental Laboratories
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Show more...
CEO
Pekerja
82
Negara
US
ISIN
US2288951088

Penyenaraian